
INOVIO Schedules Second Quarter Financial Results for August 12
Investors are looking toward August 12, when Plymouth Meeting-based INOVIO will disclose its financial performance for the second quarter of 2026. The biotechnology firm, which specializes in DNA-based treatments for HPV-related conditions and oncology, plans to pull back the curtain on its fiscal standing immediately following the market close.
























